These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 22842550)
1. Interaction of tumor cells with the immune system: implications for dendritic cell therapy and cancer progression. Imhof M; Karas I; Gomez I; Eger A; Imhof M Drug Discov Today; 2013 Jan; 18(1-2):35-42. PubMed ID: 22842550 [TBL] [Abstract][Full Text] [Related]
3. Current status and future perspectives of dendritic cell-based cancer immunotherapy. H Yi D; Appel S Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402 [TBL] [Abstract][Full Text] [Related]
4. The use of agonistic anti-CD40 therapy in treatments for cancer. Khong A; Nelson DJ; Nowak AK; Lake RA; Robinson BW Int Rev Immunol; 2012 Aug; 31(4):246-66. PubMed ID: 22804570 [TBL] [Abstract][Full Text] [Related]
5. DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy. Schultze JL; Grabbe S; von Bergwelt-Baildon MS Trends Immunol; 2004 Dec; 25(12):659-64. PubMed ID: 15530836 [TBL] [Abstract][Full Text] [Related]
6. Dendritic cell immunotherapy: mapping the way. Figdor CG; de Vries IJ; Lesterhuis WJ; Melief CJ Nat Med; 2004 May; 10(5):475-80. PubMed ID: 15122249 [TBL] [Abstract][Full Text] [Related]
8. RNA pulsed dendritic cells: an approach for cancer immunotherapy. Garg NK; Dwivedi P; Prabha P; Tyagi RK Vaccine; 2013 Feb; 31(8):1141-56. PubMed ID: 23306369 [TBL] [Abstract][Full Text] [Related]
9. Current state and perspectives of dendritic cell vaccination in cancer immunotherapy. Farkas A; Conrad C; Tonel G; Borbenyi Z; Kemeny L; Dobozy A; Nestle FO Skin Pharmacol Physiol; 2006; 19(3):124-31. PubMed ID: 16612139 [TBL] [Abstract][Full Text] [Related]
10. Potentiation strategies of dendritic cell-based antitumor vaccines: combinational therapy takes the front seat. Torabi-Rahvar M; Bozorgmehr M; Jeddi-Tehrani M; Zarnani AH Drug Discov Today; 2011 Aug; 16(15-16):733-40. PubMed ID: 21558016 [TBL] [Abstract][Full Text] [Related]
11. Current issues in dendritic cell cancer immunotherapy. López JA; Hart DN Curr Opin Mol Ther; 2002 Feb; 4(1):54-63. PubMed ID: 11885565 [TBL] [Abstract][Full Text] [Related]
13. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
14. Dendritic cell based immunotherapy--a promising therapeutic approach for endocrine malignancies. Sbiera S; Wortmann S; Fassnacht M Horm Metab Res; 2008 Feb; 40(2):89-98. PubMed ID: 18283626 [TBL] [Abstract][Full Text] [Related]
15. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy. Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535 [TBL] [Abstract][Full Text] [Related]
16. Dendritic cells in cancer immunotherapy. Gunzer M; Grabbe S Crit Rev Immunol; 2001; 21(1-3):133-45. PubMed ID: 11642600 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of cancer using dendritic cells. Morse MA; Lyerly HK Cytokines Cell Mol Ther; 1998 Mar; 4(1):35-44. PubMed ID: 9557215 [TBL] [Abstract][Full Text] [Related]
19. Cell fusion: from hybridoma to dendritic cell-based vaccine. Gong J; Koido S; Calderwood SK Expert Rev Vaccines; 2008 Sep; 7(7):1055-68. PubMed ID: 18767954 [TBL] [Abstract][Full Text] [Related]
20. [Immunology in medical practice. XXV. Use of dendritic cells in the immunotherapy of cancer]. Punt CJ; de Vries IJ; Mulders PF; Adema GJ; Figdor CG Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2408-14. PubMed ID: 10608974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]